Compare ENTA & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENTA | PDLB |
|---|---|---|
| Founded | 1995 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.5M | 393.1M |
| IPO Year | 2013 | 2017 |
| Metric | ENTA | PDLB |
|---|---|---|
| Price | $14.71 | $16.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $20.40 | N/A |
| AVG Volume (30 Days) | ★ 288.3K | 67.0K |
| Earning Date | 11-17-2025 | 01-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 142.83 |
| EPS | N/A | ★ 0.89 |
| Revenue | $65,324,000.00 | ★ $96,252,000.00 |
| Revenue This Year | $0.99 | $10.97 |
| Revenue Next Year | $0.19 | $8.59 |
| P/E Ratio | ★ N/A | $18.98 |
| Revenue Growth | N/A | ★ 26.04 |
| 52 Week Low | $4.09 | $10.88 |
| 52 Week High | $15.34 | $16.99 |
| Indicator | ENTA | PDLB |
|---|---|---|
| Relative Strength Index (RSI) | 67.09 | 70.16 |
| Support Level | $13.75 | $15.65 |
| Resistance Level | $14.79 | $16.09 |
| Average True Range (ATR) | 0.74 | 0.35 |
| MACD | -0.01 | 0.10 |
| Stochastic Oscillator | 90.89 | 99.72 |
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.